Industry News
At the movies: real-time protein production
A team of chemists at Harvard University have developed what it claims is the first technique providing a real-time, molecule-by-molecule ‘movie’ of protein production in live cells.
[ + ]Help for forensics with full-colour fingerprints
In the future, forensic investigators may take full-colour fingerprints using new technology developed by a University of Toronto-led team of international researchers.
[ + ]Geelong scores rare honour in science
Victorian city Geelong has received a rare honour in scientific circles with the inclusion of part of the city’s name in the title of a new virus.
[ + ]Cause of death surprises researchers
A research team at the University of Michigan’s College of Pharmacy set out looking for a way to kill a stubborn type of bacteria and they succeeded—but not in the way they expected.
[ + ]Microbial database launched
A publicly-available microbial database tyo host a range of microbial genome sequences has been launched by researchers at the Virginia Bioinformatics Institute at Virginia Tech.
[ + ]Viruses may be key to animal background
The University of Auckland's Faculty of Science's Dr Alexei Drummond has been part of a global research team analysing the genetic sequences of viruses in animals.
[ + ]Technique for identifying microorganisms
Scientists at the US Department of Energy's Brookhaven National Laboratory have developed a high-throughput technique for identifying the many species of microorganisms living in an unknown 'microbial community'.
[ + ]Application to characterise structure of DNA molecules
An application to enable more precise measurement of the location of a fluorescent label in a DNA layer has been developed by a team of researchers from Boston University in the US.
[ + ]Positive phase I data for Novogen's bowel disease drug
A recently completed phase I clinical trial of biopharmaceutical company Novogen's (ASX:NRT) anti-inflammatory compound NV-52 has shown rapid absorption indicating its potential as an oral therapy, according to the company. [ + ]
Zenyth in-licenses antibody patents from Ludwig
Melbourne's Zenyth Therapeutics (ASX:ZTL), formerly Amrad, has in-licensed patents from the Ludwig Institute for Cancer Research for antibodies that target a key part of the inflammatory process. [ + ]
'Frustrating' delays for Chemeq's regulatory approval
Regulatory approval for Chemeq's (ASX:CMQ) polymeric antimicrobial CHEMEQ has been delayed in some jurisdictions, pushing expected registrations out in some cases to 2007. [ + ]
Vaccine researcher critical of CSL, govt approaches to bird flu
A leading researcher has raised the ire of CSL (ASX:CSL), saying the Melbourne company is "making the wrong vaccine for bird flu." [ + ]
SCS, Chemicon launch ES cell products
Stem Cell Sciences (AIM:STEM, SCS) and Californian-based Chemicon are set to launch a new product line of culture media for mouse embryonic stem cells. [ + ]
Australians to tap into crop testing in Europe
A company has been established in Adelaide to develop scientific techniques for genetic crop testing in Europe.
[ + ]Depression vulnerability gene confirmed
An Australian replication study has strengthened evidence that individuals who inherit a common variant of the serotonin transporter gene 5-HTT are more vulnerable to major depression after adverse events in their lives. [ + ]
